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To compare coccidioidomycosis case rates among 
groups of young adults in a disease-endemic region, we 
reviewed medical charts for serologic testing and coding. 
Case rates were higher for scholarship athletes than for oth-
er students and paralleled 5× more serologic testing. Our 
ﬁ  ndings underscore the need to routinely test patients for 
coccidioidomycosis.   
C
occidioidomycosis, known commonly as valley fe-
ver, is a fungal infection endemic to the southwest-
ern United States (1). The illness most commonly caused 
is community-acquired pneumonia (2,3). Some researchers 
estimate that ≈50,000 infections are severe enough to war-
rant medical attention (1,4); however, reported infections 
represent less than a quarter of this estimate, creating un-
certainty about the true impact of valley fever. 
Scholarship athletes receive ﬁ  nancial support for their 
educations in return for participation in intercollegiate var-
sity competition. Athletes comprise a precisely deﬁ  ned 
group and afford a special opportunity to calculate endemic 
risk for infection within a young adult population. We cal-
culated case rates for scholarship athletes and then com-
pared the rates with those for other students and persons of 
college age.
The Study
The Campus Health Service at the University of Ari-
zona is located on campus in Pima County. The average 
yearly enrollment during 1998–2006 of 36,000 was used 
for calculating case rates for all students (5). Scholarship 
athletes at the university total 475 annually.
Campus Health medical charts for January 1, 1998, 
through December 31, 2006, were reviewed for serologic 
testing for coccidioidomycosis. Charts were also reviewed 
for International Classiﬁ   cation of Diseases, 9th edition 
(ICD-9), codes for coccidioidomycosis (114.0–114.5, 
114.9) to identify students in whom the diagnosis was made 
by testing elsewhere. Athletes’ charts were identiﬁ  ed based 
on billing information.
Most serologic testing, identiﬁ  ed by its current proce-
dural terminology (CPT) code, was performed by the Cam-
pus Health laboratory, which used PREMIER Coccidioides 
enzyme immunoassay (Meridian Diagnostics, Cincinnati 
OH, USA). Occasionally, ≈10% of the time, serum samples 
were tested by a single commercial laboratory, which used 
immunodiffusion testing for precipitin-type or complement 
ﬁ  xing–type antibodies (6). Any positive result was consid-
ered diagnostic. Students tested multiple times for coccid-
ioidomycosis were counted once, either in the ﬁ  rst year for 
which results were positive or in the year ﬁ  rst tested if all 
results were negative. Individual charts were reviewed for 
those students who did not have coccidioidal testing done 
at Campus Health and were included only if the diagno-
sis could be corroborated by outside laboratory documen-
tation. A case of coccidioidomycosis was deﬁ  ned as one 
in which the diagnosis could be corroborated by positive 
coccidioidal serologic results, fungal culture, or histologic 
identiﬁ  cation of spherules in biopsy specimens.
In addition, charts of all athletes who had coccidioi-
dal infection were reviewed for demographic information, 
type of sport (indoors vs. outdoors), and extent of disease. 
Arizona state statistics were provided by the Arizona De-
partment of Health Services. Not all statistics for all age 
ranges were available. All data were analyzed by using 
SPSS 11.0 for Windows (SPSS Inc, Chicago, IL, USA). 
Signiﬁ  cance tests used the Fisher exact χ2. This study was 
approved by the University of Arizona Institutional Re-
view Board and by the Campus Health Service Depart-
mental Review Committee.
Of 2,754 student medical charts selected for review 
based on routine serologic testing for coccidioidomycosis or 
an ICD-9 code for coccidioidomycosis, 305 students were 
found to have coccidioidomycosis. Of these 305, a total of 
297 had positive coccidioidomycosis results by serologic 
testing done at Campus Health and 8 were identiﬁ  ed with 
diagnostic results from other laboratories. The resulting an-
nual student case rate for all students was 94.1/100,000.
Annual rates for college students are 3–4× higher than 
available county and state rates for various age ranges 
(Table). The average age range of university students is 
17–23 years. Because Pima County statistics includes cases 
reported to the state by Campus Health, actual differences 
between student rates and nonstudent Pima County rates 
for persons of similar ages would be even greater than rep-
resented here.
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DOI: 10.3201/eid1602.090918Coccidioidal infections occurred in 16 scholarship 
athletes. The composite case rate, or annual incidence of 
coccidioidomycosis, was 374/100,000 (95% conﬁ  dence 
interval [CI] 192–639) for scholarship athletes compared 
with 90/100,000 (95% CI 79–103) for other students 
(p<0.00001). In parallel, a much greater proportion (4.6%, 
95% CI 3.9–5.4) of scholarship athletes were tested for 
coccidioidal antibodies than were other students (0.8%, 
95% CI 0.77–0.84%) (p<0.000001). Infection for all but 1 
athlete with disseminated infection was limited to the chest 
and/or skin, which resolved either untreated or after sev-
eral months of antifungal therapy. The age distribution of 
scholarship athletes was the same as for other students, and 
only 1 of 16 athletes was from Arizona. Female athletes 
with coccidioidal infections comprised 56% of the total 
compared with 41% of all uninfected athletes (p = 0.31). 
For 81% of infected athletes, sports competition took place 
outdoors, whereas 88% of uninfected athletes competed 
outdoors (p = 0.43).
Conclusions
A recent study in Arizona found that <13% of patients 
with community acquired pneumonia were tested for coc-
cidioidomycosis (7). In contrast, Campus Health Service 
at the University of Arizona tested ≈50% of students with 
community acquired pneumonia for coccidioidomycosis 
(8,9). Consequently, proportionately higher than age-ad-
justed Pima County case rates are found. Similarly, the case 
rate of 374/100,000 for scholarship athletes, >4× higher 
than that for other students, is associated with a >5-fold in-
crease in coccidioidal testing. Therefore, it would seem that 
most, if not all, of the increased case-rate for athletes can be 
accounted for by increased testing; little, if any, increased 
susceptibility can be attributed to increased exercise or ath-
letic training. We did not evaluate why clinicians tested 
more scholarship athletes. We speculate that etiologic di-
agnoses for any illness that reduced physical performance 
were sought more frequently for scholarship athletes than 
for other students. However, we cannot entirely exclude the 
possibility that the higher rate of testing was to some extent 
a consequence of higher rates of pneumonia in scholarship 
athletes. In any instance, it would appear that more com-
plete testing for community acquired pneumonia associ-
ated with valley fever does result in considerably higher 
estimates of case rates for this fungal infection.
In the past, skin test conversion rates have suggested 
an annual infection rate of ≈3,000/100,000 (10). A 2007 
telephone survey conducted by the Arizona Department of 
Health Services of persons reported with new diagnoses of 
coccidioidomycosis found that the median length of resi-
dence in an endemic area was 17 years (11), further sug-
gesting an average annual infection rate of ≈3%. In this 
context, rates for scholarship athletes fall well within these 
other estimates.
Case rates among scholarship athletes were actually 
underrepresented in outdoor sports, and the spectrum of 
disease severity was in line with that found in past studies 
of the student population as a whole (8). Many scholarship 
athletes come from regions where coccidioidomycosis is 
not endemic. Because fewer of these students had prior coc-
cidioidal infection, the annual risk for the group as a whole 
would be slightly increased as shown in a previous report 
from the same college health group (9). Arizona state sta-
tistics show a marked increase with age in case rates, e.g., 
163 cases/100,000 for persons >65 years of age. Our ﬁ  nd-
ings do not discount the possibility that immune responses 
of elderly patients differs from those of younger patients; 
disease in the elderly is more severe (12). However, our 
study suggests that at least an equal proportion of young 
adults have clinical illness from coccidioidal infection suf-
ﬁ  cient to seek medical evaluation. 
Our ﬁ  ndings address infection among college students, 
particularly scholarship athletes, and support a recommen-
dation that student health clinicians and team physicians 
consider coccidioidomycosis as a possible etiology of ill-
ness in students who live in or have traveled recently to 
disease-endemic regions. More generally, our ﬁ  ndings 
reinforce practice guidelines revised by the Infectious 
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Table. Annual case rates per 100,000 for coccidioidomycosis in University of Arizona students and in selected age groups in Pima
County, Arizona, and Arizona, USA, 1998–2006* 
Age group, y 
15–24 15–19 20–24 25–29
Year 
University of 
Arizona students  Pima County  Arizona Pima County Arizona Pima County Arizona  Pima County Arizona
1998 108
1999 61
2000 53 13.3 9.23
2001 56 13.5 12.5
2002 111 25.7 17.3
2003 69 17.4 12.0
2004 117 41 32.4 33.5 30.2 48.3 34.6 40.4 37.5
2005 147 53.2 30.1 39.7 23.6 66.3 36.7 64.9 38.4
2006 125 59.9 45.6 56.39 42.4 63.1 48.8 80.0 62.9
*The University of Arizona campus is located in Pima County. Blank cells indicate age ranges where composite statistics were not available. Coccidioidomycosis among College Students
Diseases Society of America for management of commu-
nity-acquired pneumonia to assist clinicians in evaluating 
patients with endemic exposure (13).   
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